Vitace Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.45 M
as on 24-10-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.58 M
as on 24-10-2024
- Revenue -83.15%
(FY 2023)
- Profit 47.46%
(FY 2023)
- Ebitda 52.68%
(FY 2023)
- Net Worth -4.84%
(FY 2023)
- Total Assets -7.15%
(FY 2023)
About Vitace Remedies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.45 M.
The company currently has active open charges totaling ₹0.58 M.
Pankaj Jain and Sugan Jain serve as directors at the Company.
- CIN/LLPIN
U24230MP2011PTC026005
- Company No.
026005
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Vitace Remedies Private Limited offer?
Vitace Remedies Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Syringes.
Who are the key members and board of directors at Vitace Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Jain  | Director | 18-May-2011 | Current |
| Sugan Jain | Director | 15-Mar-2014 | Current |
Financial Performance of Vitace Remedies.
Vitace Remedies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 83.15% decrease. The company also saw a substantial improvement in profitability, with a 47.46% increase in profit. The company's net worth dipped by a decrease of 4.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vitace Remedies?
In 2023, Vitace Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Mar 2021 | ₹0.58 M | Open |
How Many Employees Work at Vitace Remedies?
Unlock and access historical data on people associated with Vitace Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vitace Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vitace Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
